Medical Device Reprocessing Market by Type (Reprocessed Medical Devices), Device Category (Critical- Devices, Semi-Critical Devices, Non-Critical Devices), Application (Cardiology, Gynecology, Gastroenterology, Anesthesia) - Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

The global Medical Device Reprocessing market size was estimated at USD 2.4 billion in 2022 and is expected to surpass around USD 6.45 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 14.7% during the forecast period 2022 to 2030.

Growth in the market is mainly driven by the favorable regulatory standards for adoption of reprocessed medical devices by healthcare providers. On the other hand, the risk of infection from reprocessed medical devices may pose a threat to the market growth.

Report Scope of the Medical Device Reprocessing Market

COVID-19 Impact

Due to the COVID-19 outbreak, the medical device industry’s entire supply chain, from raw materials to manufacturing and delivery, was severely impacted. The high infection rate of COVID-19 led to increased patient admissions, diagnosis, and treatment.

Moreover, while the COVID-19 pandemic continues to disrupt economies, the increasing amount of medical waste generated has become a major concern across the world. This has further highlighted the need for efficient reprocessing, which has not only helped in meeting the supply shortages but has been responsible for promoting sustainability in healthcare. On average, a hospital generates 29 pounds of waste per bed per day, and this volume has further increased with the onset of COVID-19 by amplifying the demand for single-use medical devices. Improper management of discarded medical waste poses a health risk to the public, patients, healthcare professionals, and waste management workers. To help manage this issue, various medical device reprocessing service providers are incorporating sustainability solutions by reprocessing the dumped single use medical devices. Thereby helping reduce waste and extending the life of the products.

Medical Device Reprocessing Market Dynamics

Driver: 

Reprocessing of medical devices and equipment has gained a lot of attention in recent years, not just across healthcare facilities for saving millions of dollars annually, but among manufacturers who are seeing it as a means of achieving substantial competitive advantage. According to the Association of the Medical Devices Reprocessors (AMDR, US), on average, reprocessed medical devices are 30% to 50% cheaper than their new counterparts; due to this, medical device reprocessing has become one of the most adopted strategies for supply chain cost reduction among hospitals, surgical centers, and other healthcare facilities. This frees up funds for end users to hire additional staff, upgrade technologies, and enhance healthcare quality, among other improvements.

Restraint:

Hospital-acquired infections (HAIs) are nosocomial infections that occur during a patient’s stay at hospitals and related facilities. HAIs are not observed at admission and are considered a major cause of morbidity and mortality worldwide. Despite the existence of reprocessing guidelines and advances in device reprocessing methods, inadequate reprocessing of medical devices contribute to a significant proportion of hospital-acquired infection, where 22% of all surgical site infections (SSIs), one of the most common types of HAIs cases, are related to equipment reprocessing.

Opportunity:

Changing dynamics in a number of countries, such as France, Japan, and the Middle East & Africa, are expected to provide significant growth opportunities for medical device reprocessing. According to the AMDR, Japan is the most recent country to take steps to give hospitals access to remanufactured (commercially reprocessed) single-use medical devices. AMDR sees this as a major development for the global remanufacturing medical device industry, as Japan joins the growing number of countries that are adopting a clear regulatory path for remanufactured single-use devices. Thus, the emergence of regulatory guidelines for reprocessing medical devices in these countries provides significant opportunities for the players in this market to increase their geographic presence and garner a larger share in the medical device reprocessing market in the future.

Challenge:

Reprocessed medical devices should comply with all the standards applicable to a new medical device. The guidelines on reprocessing medical devices do not differentiate between single-use and multi-use medical devices and require the same high standards for both. The safety and performance of the reprocessed device must be equivalent to the original device and must comply with the regulatory standards for medical devices stated in the FDA and EU regulations to receive 510K approval or ISO/CE certifications for marketing in North America and Europe. The pressure to comply with these stringent regulations while reprocessing medical devices serves as a major challenge to the growth of the medical device reprocessing market.

The reprocessed support and services segment is expected to have the highest CAGR during the forecast period

Based on type, the medical device reprocessing market is segmented into reprocessing support & services and reprocessed medical devices. Reprocessing support & services segment is expected to register the highest growth during the forecast period. This is mainly due to the increasing adoption of third party reprocessing services by healthcare facilities to reduce in-house reprocessing costs.

Critical devices segment accounted for the largest share of the medical device reprocessing market in 2021

Based on the device type, the medical device reprocessing market is segmented into critical devices, semi-critical devices, and non-critical devices. In 2021, the critical devices segment accounted for the largest share of this market. The rising number of cardiac diseases and their diagnosis globally, as well as the adoption of reprocessed catheters, have further increased as a means to reduce hospital and procedure costs, thereby, driving the market growth.

The cardiology segment accounted for the largest share of the medical device reprocessing market in 2021

Based on application, the medical device reprocessing market is segmented into cardiology, gastroenterology, gynecology, arthroscopy and orthopedic surgery, general surgery & anesthesia, and other applications (urology, non-invasive surgeries, and patient monitoring). The cardiology segment accounted for the largest share of the global medical device reprocessing market in 2021. This can be attributed to the increasing prevalence of cardiac diseases leading to higher demand for diagnostic and cardiac procedures. The increasing diagnostic and surgical procedures in the specialty area is thereby responsible for the adoption of reprocessed medical devices, as a means to reduce costs associated with buying new device for every new procedure.

Asia Pacific segment is expected to register the highest CAGR during the forecast period

North America accounted for the largest share of the medical device reprocessing market in 2021. However, the medical device reprocessing market in the Asia Pacific is expected to register the highest growth during the forecast period. This can be attributed to the growing economy, the increasing prevalence of chronic diseases, and the growing need to reduce hospital costs.

Some of the prominent players in the Medical Device Reprocessing Market include:  Stryker Corporation (US), Johnson & Johnson (US), Vanguard AG (Germany), Medtronic PLC (Ireland), Steris Healthcare (US), Medline ReNewal (US), Innovative Health (US), Arjo Group (ReNu Medical, Inc.) (Sweden), SteriPro Canada, INC. (Canada), Northeast Scientific, INC. (US), Cardinal Health (Sustainable Technologies) (US).

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Medical Device Reprocessing market

Global Medical Device Reprocessing Market, by Type

• Reprocessing Support & Services
• Reprocessed medical devices

Global Medical Device Reprocessing Market, by Device Category

• Critical Devices
• Semi- Critical Devices
• Non- Critical Devices

Global Medical Device Reprocessing Market, by Application

• Cardiology
• Gastroenterology
• Gynecology
• Arthroscopy & Orthopedic Surgery
• General Surgery and Anesthesia
• Other Applications (Urology, non-invasive surgeries, patient monitoring)

By Geography

North America

• U.S.
• Canada

Europe

• Germany
• France
• United Kingdom
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Rest of Latin America

Middle East & Africa (MEA)

• GCC
• North Africa
• South Africa
• Rest of Middle East & Africa

Key Points Covered in Medical Device Reprocessing Market Study:

• Growth of Medical Device Reprocessing in 2022
• Market Estimates and Forecasts (2017-2030)
•  Brand Share and Market Share Analysis
•  Key Drivers and Restraints Shaping Market Growth
•  Segment-wise, Country-wise, and Region-wise Analysis
•  Competition Mapping and Benchmarking
•  Recommendation on Key Winning Strategies
•  COVID-19 Impact on Demand for Medical Device Reprocessing and How to Navigate
•  Key Product Innovations and Regulatory Climate
•  Medical Device Reprocessing Consumption Analysis
•  Medical Device Reprocessing Production Analysis
•  Medical Device Reprocessing and Management